Browse everything: Tickers A–Z · Issuers · Comparisons · Tags
INDP Stock — Indaptus Therapeutics Inc
Indaptus Therapeutics Inc (INDP)
Updated October 16, 2026.
INDP is a Stock. Total return is -99.6% over the past 13.8 years, 679.3 points behind SPY at 579.7%.
Indaptus Therapeutics is a clinical biotechnology company developing immunotherapy products for cancer and viral infections, with its lead candidate Decoy20 in development for lymphoma, hepatocellular carcinoma, colorectal cancer, pancreatic cancer, chronic hepatitis B, and HIV, as well as advanced solid tumors. The company does not currently distribute to shareholders. This security appeals to investors seeking exposure to early-stage biotech development rather than those focused on generating current income.
INDP dividend yield and income
Price as of 2026-10-16.
The payment date is 10/30/2020.
INDP performance versus SPY
Price and return data through 2026-10-16.
Total return is -99.6% over the past 13.8 years, 679.3 points behind SPY at 579.7%. Over the past year its total return — price change plus distributions reinvested — is -23.3%. Its deepest 1-year drawdown was 80.3%.
| Window | Total return | CAGR |
|---|---|---|
| 1M | -18.1% | — |
| 3M | 4.0% | — |
| 6M | -13.5% | — |
| YTD | -9.6% | — |
| 1Y | -23.3% | — |
| 2Y CAGR | — | -74.40% |
| 3Y CAGR | — | -66.80% |
| 5Y CAGR | — | -58.70% |
| 10Y CAGR | — | -56.80% |
| Since inception (13.8 years) | -99.6% | -33.50% |
INDP key facts
- Asset type
- Stock
- Asset class
- Equity
- Inception date
- 12/26/2012
- Distribution frequency
- None
- Last close
- $2.63 (as of 2026-10-16)
- Market cap
- $350,427,312
- Average volume
- 496183.0
- Payment date
- 10/30/2020
- Beta
- 0.973
- Payout ratio
- 0.0%
- EPS
- $-6.15
How Dividend Vision calculates yield and returns
Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.
Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology
Sources and review
Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.
Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.
INDP risks and drawbacks
Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 80.3%.
Who may consider INDP — and who may not
It is a weaker fit for investors who need monthly cash flow (INDP does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.
More on INDP
Frequently asked questions
Does INDP pay monthly?
No. INDP does not currently distribute.
When does INDP pay a dividend?
INDP does not currently distribute. The payment date is 10/30/2020.
How has INDP performed?
Total return is -99.6% over the past 13.8 years, 679.3 points behind SPY at 579.7%. Over the past year its total return — price change plus distributions reinvested — is -23.3%. Its deepest 1-year drawdown was 80.3%.
Tickers
Holdings as-of date unavailable.
| Ticker | Name | Weight |
|---|
See how this investment would fit into your portfolio.